Cosima Tatiana Baldari

21PUBLICATIONS
102CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineMolecular targetsInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 04, 2026
Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4.

|Jul 03, 2026
Human CD8-iTreg are potent GVHD suppressors and tumoricidal effectors by release of Granzyme-K + Supramolecular Attack Particles.

|May 21, 2025
Human monoclonal antibodies targeting subdominant meningococcal antigens confer cross-protection against gonococcus.

Marco Troisi, Monica Fabbrini, Samuele Stazzoni

|May 19, 2025
IFT20 regulates TFEB-dependent lytic granule biogenesis in cytotoxic T lymphocytes by orchestrating the MPR-dependent transport of granzyme B.

Francesca Finetti, Fabrizia Zevolini, Loredana Migliore

|Feb 04, 2025
Activation-induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles.

Chiara Cassioli, Nagaja Capitani, Claire C Staton

|Feb 15, 2024
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia.

Gioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti

Pageof 4

Frequent Collaborators

7 joint publications

Francesca Finetti

6 joint publications

Chiara Cassioli

6 joint publications

Laura Patrussi

6 joint publications

Nagaja Capitani